Blood-brain barrier transport of morphine in patients with severe brain trauma.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1365-2125.2003.02032.XPMID 15025740PMCID PMC1884477
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Morphine Blood-Brain Barrier Transport Is Influenced by Probenecid Co-Administration

  2003cited by this paper
• Interaction of Morphine, Fentanyl, Sufentanil, Alfentanil, and Loperamide with the Efflux Drug Transporter P-glycoprotein

  2002cited by this paper
• Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.

  2002cited by this paper
• Theory relating in vitro and in vivo microdialysis with one or two probes

  2002cited by this paper
• Brain energy metabolism during controlled reduction of cerebral perfusion pressure in severe head injuries

  2001cited by this paper
• Intracerebral microdialysis and bedside biochemical analysis in patients with fatal traumatic brain lesions

  2001cited by this paper
• Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs

  2001cited by this paper
• The Multidrug Resistance P-glycoprotein

  2001cited by this paper
• Pharmacokinetic-Pharmacodynamic Modelling of Morphine Transport Across the Blood-Brain Barrier as a Cause of the Antinociceptive Effect Delay in Rats—A Microdialysis Study

  2000cited by this paper
• Intracerebral Microdialysis in Clinical Practice: Baseline Values for Chemical Markers during Wakefulness, Anesthesia, and Neurosurgery

  2000cited by this paper
• Target-Controlled Infusion Systems

  2000cited by this paper
• Increased drug delivery to the brain by P‐glycoprotein inhibition

  2000cited by this paper
• Elevated concentrations of morphine 6‐beta‐D‐glucuronide in brain extracellular fluid despite low blood–brain barrier permeability

  1999cited by this paper
• Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.

  1999cited by this paper
• Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

  1999cited by this paper
• The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) mice

  1999cited by this paper
• Methodological Aspects of the Use of a Calibrator in In Vivo Microdialysis–Further Development of the Retrodialysis Method

  1998cited by this paper
• Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain

  1998cited by this paper
• Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation.

  1998cited by this paper
• [Brain energy metabolism].

  1997cited by this paper
• The multidrug resistance P-glycoprotein.

  1993cited by this paper
• Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine‐6‐glucuronide

  1990cited by this paper
• Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro.

  1990cited by this paper
• An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites.

  1988cited by this paper
• Brain energy metabolism

  1978cited by this paper

• Assessing central nervous system drug delivery

  2025influential citation
• Effusol, a unique Juncus effusus phenanthrene, ameliorates amyloid β1-42-mediated neurotoxicity in mice

  2025cites this paper
• PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans

  2024influential citation
• Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics

  2024cites this paper
• The effect of morphine on rat microglial phagocytic activity: an in vitro study of brain region-, plating density-, sex-, morphine concentration-, and receptor-dependency

  2023influential citation
• Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review

  2023cites this paper
• Bedside interpretation of cerebral energy metabolism utilizing microdialysis in neurosurgical and general intensive care

  2022cites this paper
• Understanding the Blood‐Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics

  2022cites this paper
• Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development

  2022cites this paper
• A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance

  2022cites this paper
• Shedding Light on the Blood–Brain Barrier Transport with Two-Photon Microscopy In Vivo

  2022cites this paper
• Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview

  2021cites this paper
• Impact of CNS Diseases on Drug Delivery to Brain Extracellular and Intracellular Target Sites in Human: A “WHAT-IF” Simulation Study

  2021cites this paper
• Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations

  2021cites this paper
• Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children

  2021cites this paper
• Neurointensive Care Unit as a Platform for Advanced Clinical Research

  2020cites this paper
• Combining Brain Microdialysis and Translational Pharmacokinetic Modeling to Predict Drug Concentrations in Pediatric Severe Traumatic Brain Injury: The Next Step Toward Evidence-Based Pharmacotherapy?

  2019cites this paper
• Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes

  2019cites this paper
• Prediction of human CNS pharmacokinetics using a physiologically‐based pharmacokinetic modeling approach

  2018cites this paper
• Morphine Binds Creatine Kinase B and Inhibits Its Activity

  2018cites this paper
• Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine

  2018cites this paper
• Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics

  2018cites this paper
• Rate and extent of mitragynine and 7‐hydroxymitragynine blood–brain barrier transport and their intra‐brain distribution: the missing link in pharmacodynamic studies

  2018cites this paper
• Opioids and the Blood-Brain Barrier: A Dynamic Interaction with 
Consequences on Drug Disposition in Brain

  2017cites this paper
• Natural Compounds as a Therapeutic Intervention following Traumatic Brain Injury: The Role of Phytochemicals

  2017cites this paper
• Cerebrospinal fluid and brain extracellular fluid in severe brain trauma.

  2017cites this paper
• Aspects on the Physiological and Biochemical Foundations of Neurocritical Care

  2017cites this paper
• Microdialysis as an Important Technique in Systems Pharmacology—a Historical and Methodological Review

  2017cites this paper
• Microdialysate concentration changes do not provide sufficient information to evaluate metabolic effects of lactate supplementation in brain-injured patients

  2016cites this paper
• An introduction to physiologically‐based pharmacokinetic models

  2016cites this paper
• A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations

  2016cites this paper
• Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects

  2016cites this paper
• The relationship between methylation and genes associated with opioid response in humans

  2016cites this paper
• A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain.

  2015cites this paper
• PBPK Modeling Approach for Predictions of Human CNS Drug Brain Distribution

  2015cites this paper
• Translational aspects of blood–brain barrier transport and central nervous system effects of drugs: From discovery to patients

  2015cites this paper
• PKPD Aspects of Brain Drug Delivery in a Translational Perspective

  2014cites this paper
• Pharmacokinetic Concepts in Brain Drug Delivery

  2014cites this paper
• Utility of CSF in translational neuroscience

  2013cites this paper
• Nicotine-morphine interactions at α4β2, α7 and α3(⁎) nicotinic acetylcholine receptors.

  2013cites this paper
• Surgery‐induced inflammation reduces morphine distribution into cerebrospinal fluid

  2013cites this paper
• Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.

  2013cites this paper
• Molecular and cellular pharmacology Nicotine – morphine interactions at a 4 b 2 , a 7 and a 3 n nicotinic acetylcholine receptors

  2013influential citation
• Methods to measure target site penetration of antibiotics in critically ill patients.

  2013cites this paper
• Translational Approaches for Predicting CNS Drug Effects Using Microdialysis

  2013cites this paper
• Utility of CSF in translational neuroscience

  2013cites this paper
• The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects

  2013cites this paper
• Microdialysis in CNS PKPD Research : Unraveling Unbound Concentrations

  2013cites this paper
• The Neurointensive Care Unit as a Platform for Advanced Clinical Research

  2012cites this paper
• Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein^+ cancers

  2012cites this paper
• The importance and pitfalls of correlational science in palliative care research

  2012cites this paper
• Analytical methods for brain targeted delivery system in vivo: perspectives on imaging modalities and microdialysis.

  2012cites this paper
• Morphine Brain Pharmacokinetics at Very Low Concentrations Studied with Accelerator Mass Spectrometry and Liquid Chromatography-Tandem Mass Spectrometry

  2011cites this paper
• Effect of Cytochrome P450 2D6 and 3A Enzyme Inhibition on the Metabolism of Oxycodone

  2011cites this paper
• Brain Microdialysis Study of Meropenem in Two Patients with Acute Brain Injury

  2010influential citation
• Exploring New Routes for Neuroprotective Drug Development in Traumatic Brain Injury

  2010cites this paper
• Pharmacokinetics I: PK-PD approaches - antibiotic drug development

  2010cites this paper
• Rapid, Reversible Modulation of Blood–Brain BarrierP-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor

  2010cites this paper
• The Use of In Vitro Unbound Drug Fraction and Permeability in Predicting Central Nervous System Drug Penetration

  2010cites this paper
• The Blood – Brain Barrier and its Effect on Absorption and Distribution

  2010cites this paper
• Drug Administration and Distribution

  2010cites this paper
• Cerebral energy metabolism and microdialysis in neurocritical care

  2010cites this paper
• Physiologically-based Pharmacokinetic (PBPK) Models for the Description of Sequential Metabolism of Codeine to Morphine and Morphine 3-Glucuronide (M3G) in Man and Rat

  2010cites this paper
• , Two Patients with Acute Brain Injury Brain Microdialysis Study of Meropenem in

  2010influential citation
• Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3‐ and 6‐glucuronide in the human brain *

  2009cites this paper
• Pharmacokinetics, pharmacodynamics and drug monitoring in critical illness

  2009cites this paper
• The influence of age on the distribution of morphine and morphine‐3‐glucuronide across the blood–brain barrier in sheep

  2009cites this paper
• An Update on Substance Use and Treatment following Traumatic Brain Injury

  2008cites this paper
• Clinical Microdialysis in Skin and Soft Tissues: An Update

  2008cites this paper
• Microdialyse cérébrale : méthodologie et applications cliniques

  2008cites this paper
• Blood–Brain Barrier Transport Helps to Explain Discrepancies in In Vivo Potency between Oxycodone and Morphine

  2008cites this paper
• Microdialysis in the human brain and its potential role in the development and clinical assessment of drugs.

  2007cites this paper
• On The Rate and Extent of Drug Delivery to the Brain

  2007cites this paper
• An audit of the safety and effectiveness of an alfentanil:morphine mixture in the postanaesthesia care unit

  2007cites this paper
• AAPS-FDA workshop white paper: Microdialysis principles, application, and regulatory perspectives report from the Joint AAPS-FDA Workshop, November 4–5, 2005, Nashville, TN

  2007cites this paper
• AAPS‐FDA Workshop White Paper: Microdialysis Principles, Application, and Regulatory Perspectives

  2007cites this paper
• Experimental approaches to measuring brain exposure: Rate, extent and regional distribution

  2007cites this paper
• CEREBRAL UPTAKE OF DRUGS IN HUMANS

  2007cites this paper
• Chapter 6.5 Assaying protein-unbound drugs using microdialysis techniques

  2006cites this paper
• Microdialyse et agression cérébrale : importance des études animales

  2006cites this paper
• [Microdialysis and brain injury: importance of animal study].

  2006cites this paper
• Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution

  2006cites this paper
• Chapter 6.4 Microdialysis as a method to study blood-brain barrier transport mechanisms

  2006cites this paper
• Chapter 6.6 Microdialysis for characterization of PK/PD relationships

  2006cites this paper
• Application of microdialysis in clinical pharmacology.

  2006cites this paper
• Continuous monitoring of cerebral metabolism in traumatic brain injury: a focus on cerebral microdialysis

  2006cites this paper
• Microdialysis: principles and techniques

  2006cites this paper
• AAPS-FDA Workshop White Paper: Microdialysis Principles, Application and Regulatory Perspectives

  2006cites this paper
• Endogenous opiates and behavior: 2004.

  2005cites this paper
• Microdialysis--theoretical background and recent implementation in applied life-sciences.

  2005cites this paper
• Intracerebral microdialysis in severe brain trauma: the importance of catheter location.

  2005cites this paper
• Ventilatory responses of healthy subjects to intravenous combinations of morphine and oxycodone under imposed hypercapnic and hypoxaemic conditions.

  2005cites this paper
• Pharmacokinetic studies with PET.

  2005cites this paper
• Monitoring of head injured patients

  2005cites this paper
• Lessons we have learnt from microdialysis in animals and humans

  2005cites this paper
• Treating Intracranial Hypertension in Patients with Severe Traumatic Brain Injury during Neurointensive Care

  2005cites this paper
• Methods to assess tissue-specific distribution and metabolism of drugs.

  2004cites this paper
• Assessment of critical thresholds for cerebral perfusion pressure by performing bedside monitoring of cerebral energy metabolism.

  2003cites this paper
• icrodialyse cérébrale : méthodologie et pplications cliniques rain microdialysis : Methodology and clinical

  year unknowncites this paper
• Assessing central nervous system drug delivery

  year unknowninfluential citation